Search

Will it ever happen?

Audiology is a rapidly evolving field, with many exciting developments on the horizon. David Baguley identified some topics of interest, and asked some international experts ‘will it ever happen?’ Gene therapy for deafness After years of development, gene therapy for...

Pre-clinical development of magnetic delivery of therapy to middle and inner ears

Why are we developing this technology? A key problem in drug delivery is getting the therapy to the right place in the body, which is especially challenging for targets that are small, deep and are protected or surrounded by anatomical...

Music, hearing, and education: from the lab to the classroom

Historically, research assessing the impact of musical training has focused on those children whose families are able to pay for private lessons. In this article however, Nina Kraus outlines the findings of one of her recent projects; assessing the impact...

A parent’s journey: beyond the diagnosis

Tamsin Coates lives in Wallesey, UK and talks about coming to terms with the difficulties and joys of having two deaf children. Here she explains about the early days and the impact of their diagnosis upon the family. Thinking back...

A cognitive therapy programme for hearing impairment: reducing avoidance and mental distress

Cognitive behavioural therapy (CBT), a psychotherapeutic treatment method, is most commonly used to treat anxiety and depression. Newly published results from a controlled, clinical study demonstrate that an adapted CBT programme is useful for several common challenges in aural rehabilitation;...

Conspiring together: tinnitus and hearing loss

In this special feature, Nic Wray of the British Tinnitus Association and Zheng Yen Ng of The Ear Foundation present the results of their report into managing tinnitus for people with hearing loss. In September 2015, the British Tinnitus Association...

Unanswered questions in adult ototoxicity associated with platinum-based chemotherapy

Do the potential side-effects on hearing and tinnitus need to be a ‘necessary evil’ of platinum-based chemotherapy? How strong is our evidence base when offering advice to patients and fellow clinicians? David Baguley and his team from the University of...

The role of public health in addressing age-related hearing loss

Prevention and treatment of hearing loss needs to be viewed through a public health lens, but what does that look like? Kelly Reavis and colleagues explain the steps to addressing hearing healthcare from a public health perspective and why this...

Hearing aid outcomes in older adults: what and when to measure

What matters to older adults when purchasing a hearing aid? Larry Humes explores the domains that should be measured for this key group. This article identifies key domains of hearing aid outcome in older adults. Increasingly, third-party payers and private-pay...

Hyperacusis-related distress and comorbid psychiatric illness

Research suggests that over 50% of patients presenting with hyperacusis also present with some form of psychiatric disorder. With this in mind, Dr Aazh outlines what tools clinicians can use to screen for psychological disorders and what path to take...

Remote care apps: comparing the options

With much of the world in full or partial lockdown and social-distancing measures in full swing, the COVID-19 crisis has sparked renewed interest in remote teleaudiology services. Modern teleaudiology platforms, now offered by all major hearing aid brands, offer audiologists...

Precision and personalised genomic and epigenomic medicine in audiology/hearing loss

A detailed look at the pathogenesis of acquired hearing loss due to exposure to ototoxicity during pregnancy or shortly after birth. Insights from genomic medicine have shown that, along with environmental factors causing epigenetic alterations, hearing loss may be caused...